Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Haemophilia ; 20(3): 421-5, 2014 May.
Article in English | MEDLINE | ID: mdl-24330418

ABSTRACT

The penetration of beta energy of 153-samarium ((153) Sm) (0.8 MeV) is not only appropriate for synovectomy of median articulations but is possible to improve the radiobiological effect using increased activities. The aim of this study was to assess the effectiveness of 185 MBq and 740 MBq of 153-samarium hydroxyapatite ((153) Sm-HA) in knees of haemophilic patients. Thirty-one patients--36 knees, 30 males, were divided into two groups without coinjection of corticosteroid: A - 14 patients (17 knees) treated with intra-articular dose of 185 MBq of (153) Sm-HA, average age 23 years; B--17 patients (19 knees) with 740 MBq of (153) Sm-HA, average age 21.3 years. The evaluation before and after 1 year of synovectomy used the following criteria: reduction in the number of haemarthroses and use of the coagulation factor and improvement in articular motility. Adverse-effects occurrence was considered too. Early and late scintigraphic studies were performed after synoviorthesis and no joint immobilization was recommended. The reduction in haemarthrosis and use of coagulation factor were: group 1--31.3% and 25%; group 2--81.5% and 79% with P < 0.001 respectively; no significant improvement in knees motility was noted for both groups. Four cases of mild reactional synovitis were observed in each group. The scintigraphic control showed homogenous distribution of the radiopharmaceuticals with no articular escape; the material was considered safe by its permanence in the articulation. We have significant improvement in the synovectomy of haemophilic knees with 740 MBq of (153) Sm-HA; the less penetration of its beta radiation was compensated by the increased biological effect with the higher used activity.


Subject(s)
Hemarthrosis/radiotherapy , Hemophilia A/complications , Hydroxyapatites/administration & dosage , Radioisotopes/administration & dosage , Samarium/administration & dosage , Synovitis/etiology , Synovitis/radiotherapy , Adolescent , Child , Dose-Response Relationship, Radiation , Female , Hemarthrosis/etiology , Hemarthrosis/metabolism , Humans , Hydroxyapatites/pharmacokinetics , Injections, Intra-Articular , Knee Joint/metabolism , Knee Joint/physiopathology , Knee Joint/radiation effects , Male , Prospective Studies , Samarium/pharmacokinetics , Synovitis/metabolism , Treatment Outcome , Young Adult
2.
Haemophilia ; 15(1): 240-6, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18976248

ABSTRACT

The aim is to evaluate the efficiency of the treatment with 153-samarium hydroxyapatite (153-Sm-HA) in haemophilic arthropathy. Thirty-one patients (30 males) with ages ranging from 8 to 34 years (average age = 20.6 years) were treated with fixed intra-articular dose of 185 MBq (5 mCi) and divided into two groups: infantile-juvenile (13 patients with up to 18 years of age, an average age of 12.7 years and arthropathy evolution of 7.8 years), and adult (18 patients older than 18 years, an average age of 24 years and arthropathy evolution of 18.7 years). The clinical evaluation before and after 1 year of synovectomy used the following criteria: subjective (pain through visual scale, articulation inspection), objective (articular movement through flexion level, sensitivity to palpation and leakage through joint circumference), reduction on the use of the coagulation factor, number of haemarthrosis, and the occurrence of adverse effects. The results were classified as: 1, good (remission from 70% to 100% of manifestations); 2, moderate (remission from 40% to 69%); and 3, poor (remission from 0% to 39%). Seventy-eight joints were tested: 15 knees, 36 elbows, 24 ankles, 1 shoulder and 2 hips. Early scintigraphic (1-2 h) and late scintigraphic (24-72 h) studies were performed after synoviorthesis. The cost of the procedure per joint was also estimated. No significant difference in the synoviorthesis result between groups was observed. The results were good for 75% of elbows, 87.5% of ankles and 40% of knees; the reduction in haemarthrosis and use of the coagulation factor was respectively 78% and 80% for elbows, 82% and 85% for ankles and 30% and 35% for knees. Four cases of reactional synovitis were observed in the 31 patients. The scintigraphic control showed homogeneous distribution of the material with no articular escape. The use of 153 Sm-HA in the treatment of the haemophilic arthropathy is effective for intermediate-size joints (elbows and ankles), but less effective for knees. Moreover, this treatment presents an excellent safety profile and accessible cost.


Subject(s)
Hemarthrosis/radiotherapy , Hemophilia A/complications , Hydroxyapatites/therapeutic use , Samarium/therapeutic use , Synovial Membrane/radiation effects , Synovitis/radiotherapy , Adolescent , Adult , Age Factors , Child , Female , Hemarthrosis/diagnostic imaging , Hemarthrosis/etiology , Humans , Hydroxyapatites/administration & dosage , Hydroxyapatites/pharmacokinetics , Injections, Intra-Articular , Male , Prospective Studies , Radioisotopes/administration & dosage , Radioisotopes/pharmacokinetics , Radioisotopes/therapeutic use , Radionuclide Imaging , Samarium/administration & dosage , Samarium/pharmacokinetics , Synovitis/diagnostic imaging , Synovitis/etiology , Treatment Outcome , Young Adult
3.
Phys Rev Lett ; 98(4): 045503, 2007 Jan 26.
Article in English | MEDLINE | ID: mdl-17358786

ABSTRACT

In a series of experiments in externally electrically heated diamond anvil cells we demonstrate that at pressures above approximately 240 GPa gold adopts a hexagonal-close-packed structure. Ab initio calculations predict that at pressures about 250 GPa different stacking sequences of close-packed atomic layers in gold become virtually degenerate in energy, strongly supporting the experimental observations.

SELECTION OF CITATIONS
SEARCH DETAIL
...